Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc. financial statements

Eikon Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 324.25MEODHD
Cash and equivalentsUSD 104.9MEODHD
Total debtUSD 257.32MEODHD

Eikon Therapeutics, Inc. financials on 6ix · Eikon Therapeutics, Inc. on 6ix